Gastrointestinal Endoscopic Device Market Report Suite | United States | 2019-2025 | MedSuite (Includes 13 reports)

iData Research
676 Pages - IDR10511
$10,995.00

In 2018, the largest segment in the GI endoscopic device market was the GI endoscope market. The majority of total GI endoscope unit sales consisted of colonoscopes used in the hospital setting, either at a designated endoscopy room or general surgery suite, with the balance being used in the outpatient centers. Although there is a general downward trend in prices across the GI endoscope segments, it will be moderated by an upward trend in segments such as colonoscopes, where users are converting towards new premium-priced products.

'

TABLE OF CONTENTS I
LIST OF FIGURES XIV
LIST OF CHARTS XXXII
EXECUTIVE SUMMARY 1
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 14
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
DISEASE OVERVIEW 30
2.1 BASIC ANATOMY 30
2.2 DISEASE TREATMENT & DIAGNOSTICS 32
2.2.1 Gastroesophageal Reflux Disease 32
2.2.2 Barrett’s Esophagus 34
2.2.3 GI Cancer 34
2.2.4 GI bleeding 37
2.2.5 Bile Duct Diseases 38
2.2.6 Crohn’s Disease 39
2.2.7 Peptic Ulcer Disease 40
2.2.8 Intestinal Pseudo-Obstruction and Ogilvie Syndrome 40
2.3 PATIENT DEMOGRAPHICS 42
2.3.1 GI Disorders 42
2.3.1.1 General Statistics of GI Disorders for Different Years for the United States 43
2.3.1.2 Abdominal Wall Hernia 44
2.3.1.3 Chronic Constipation 45
2.3.1.4 Diverticular Disease 45
2.3.1.5 Prescriptions 45
2.3.1.6 Gastroesophageal Reflux Disease 45
2.3.1.7 Gastrointestinal Infections 46
2.3.1.8 Hemorrhoids 46
2.3.1.9 Inflammatory Bowel Disease 46
2.3.1.10 Liver Disease 47
2.3.1.11 Pancreatitis 47
2.3.1.12 Peptic Ulcer Diseases 47
2.3.2 GI Cancers 48
PRODUCT ASSESSMENT 49
3.1 INTRODUCTION 49
3.2 PRODUCT PORTFOLIOS 49
3.2.1 GI Endoscopy 49
3.2.2 Capsule Endoscopy 55
3.2.3 Virtual Colonoscopy 58
3.2.4 Stenting and Dilation Devices 60
3.2.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices 63
3.2.6 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 67
3.2.7 Foreign Body Retrieval and Specimen Removal Devices 69
3.2.8 Hemostasis Devices 71
3.2.9 Enteral Feeding Devices 74
3.2.10 Anti-Reflux Devices 78
3.2.11 Barrett’s Esophagus Ablation Devices 80
3.3 FDA RECALLS 82
3.3.1 Boston Scientific 82
3.3.1.1 ERCP 82
3.3.2 Cook Medical 84
3.3.2.1 Stenting and Dilation Devices 84
3.3.2.2 Biopsy Forceps, Polypectomy Snares and Fine-Needle Aspiration 85
3.3.2.3 Hemostasis Devices 85
3.3.3 Fujifilm 86
3.3.4 Avanos Medical 88
3.3.4.1 Enteral Feeding 88
3.3.5 Olympus 89
3.3.5.1 Gastrointestinal Endoscopy 89
3.3.6 Pentax Medical 91
3.3.6.1 Gastrointestinal Endoscopy 91
3.3.7 US Endoscopy 94
3.3.7.1 Foreign Body Retrieval and Specimen Removal 94
3.4 CLINICAL TRIALS 95
3.4.1 Boston Scientific 95
3.4.1.1 Stenting & Dilation 95
3.4.1.2 ERCP 98
3.4.1.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 108
3.4.1.4 Hemostasis Devices 112
3.4.2 Cook Medical 113
3.4.2.1 Stenting and Dilation Devices 113
3.4.2.2 ERCP 115
3.4.2.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 119
3.4.2.4 Hemostasis Devices 123
3.4.3 EndoGastric 125
3.4.3.1 Anti-Reflux Devices for Treatment of GERD 125
3.4.4 ERBE 128
3.4.4.1 Hemostasis Devices 128
3.4.5 Fujifilm 130
3.4.6 Medtronic 133
3.4.6.1 Capsule Endoscopy 133
3.4.6.2 Barrett’s Esophagus Ablation Devices 139
3.4.7 Olympus 143
3.4.7.1 Gastrointestinal Endoscopy 143
3.4.7.2 Capsule Endoscopy 155
3.4.7.3 Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration 156
3.4.7.4 Hemostasis Devices 158
3.4.8 Pentax Medical 160
3.4.8.1 Gastrointestinal Endoscopy 160
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 164
4.1 INTRODUCTION 164
4.2 MARKET OVERVIEW 165
4.3 TREND ANALYSIS BY SEGMENT 172
4.4 DRIVERS AND LIMITERS 176
4.4.1 Market Drivers 176
4.4.2 Market Limiters 177
4.5 COMPETITIVE MARKET SHARE ANALYSIS 179
4.6 MERGERS AND ACQUISITIONS 185
4.7 COMPANY PROFILES 186
4.7.1 Boston Scientific 186
4.7.2 Cardinal Health 188
4.7.3 CONMED 190
4.7.4 Cook Medical 191
4.7.5 EndoGastric Solutions 192
4.7.6 ERBE 193
4.7.7 Fujifilm 194
4.7.8 GE Healthcare 196
4.7.9 Avanos Medical 197
4.7.10 Medline 198
4.7.11 Medtronic 200
4.7.12 Olympus 202
4.7.13 Pentax Medical 204
4.7.14 Siemens Healthineers 205
4.7.15 STERIS 206
4.7.16 US Endoscopy 207
4.7.17 Vital Images, Inc. 208
4.8 SWOT ANALYSIS 209
4.8.1 Boston Scientific 210
4.8.2 Cardinal Health 212
4.8.3 CONMED 214
4.8.4 Cook Medical 216
4.8.5 EndoGastric Solutions 218
4.8.6 ERBE 219
4.8.7 Fujifilm 220
4.8.8 GE Healthcare 223
4.8.9 Avanos Medical 225
4.8.10 Medline 227
4.8.11 Medtronic 229
4.8.12 Olympus 231
4.8.13 Pentax Medical 233
4.8.14 Siemens Healthineers 234
4.8.15 STERIS 236
4.8.16 US Endoscopy 237
4.8.17 Vital Images, Inc. 238
PROCEDURE NUMBERS 239
5.1 INTRODUCTION 239
5.2 PROCEDURES 240
5.2.1 Procedure Overview 240
5.2.2 Gastrointestinal Endoscopy Procedures 244
5.2.2.1 EGD Procedures 244
5.2.2.2 Colonoscopy Procedures 244
5.2.2.3 Sigmoidoscopy Procedures 244
5.2.2.4 Enteroscopy Procedures 244
5.2.2.5 Ultrasound Endoscopy Procedures 245
5.2.2.6 ERCP Procedures 245
5.2.3 Capsule Endoscopy Procedures 249
5.2.4 Virtual Endoscopy Procedures 251
5.2.5 Stenting Procedures 253
5.2.6 Dilation Procedures 255
5.2.7 Tissue Biopsy Procedures 257
5.2.8 Polypectomy Snare Procedures 259
5.2.9 Specimen Retrieval Procedures 261
5.2.10 Foreign-Body Removal Procedures 263
5.2.11 Hemostasis Procedures 265
5.2.12 Enteral Feeding Tube Placement Procedures 267
5.2.13 Anti-Reflux Device Implantation Procedures 269
5.2.14 Barrett’s Esophagus Ablation Procedures 271
GASTROINTESTINAL ENDOSCOPE MARKET 273
6.1 INTRODUCTION 273
6.2 MARKET OVERVIEW 275
6.3 MARKET ANALYSIS AND FORECAST 281
6.3.1 Total Gastrointestinal Endoscope Market 281
6.3.2 Colonoscope Market 283
6.3.3 Sigmoidoscope Market 286
6.3.4 Duodenoscope Market 288
6.3.5 Enteroscope Market 290
6.3.6 Ultrasound Endoscope Market 292
6.3.7 Double-Balloon Endoscope Market 294
6.3.8 Gastroscope Market 296
6.3.9 Third-Party Refurbished Endoscope Market 298
6.4 DRIVERS AND LIMITERS 300
6.4.1 Market Drivers 300
6.4.2 Market Limiters 301
6.5 COMPETITIVE MARKET SHARE ANALYSIS 303
6.5.1 Gastrointestinal Endoscope 303
6.5.2 Third-Party Endoscope Resale and Repair Market 307
CAPSULE ENDOSCOPY MARKET 310
7.1 INTRODUCTION 310
7.2 MARKET OVERVIEW 312
7.3 MARKET ANALYSIS AND FORECAST 316
7.3.1 Camera Capsule Market 316
7.3.2 Workstation Market 319
7.3.3 Data Recorder Market 321
7.4 DRIVERS AND LIMITERS 323
7.4.1 Market Drivers 323
7.4.2 Market Limiters 324
7.5 COMPETITIVE MARKET SHARE ANALYSIS 326
VIRTUAL COLONOSCOPY SOFTWARE MARKET 329
8.1 INTRODUCTION 329
8.2 MARKET ANALYSIS AND FORECAST 331
8.3 DRIVERS AND LIMITERS 334
8.3.1 Market Drivers 334
8.3.2 Market Limiters 335
8.4 COMPETITIVE MARKET SHARE ANALYSIS 337
STENTING AND DILATION DEVICE MARKET 341
9.1 INTRODUCTION 341
9.2 MARKET OVERVIEW 343
9.3 MARKET ANALYSIS AND FORECAST 348
9.3.1 Total Esophageal Stent Market 348
9.3.1.1 Esophageal Covered-Metal Stent Market 353
9.3.1.2 Esophageal Bare-Metal Stent Market 355
9.3.1.3 Esophageal Plastic Stent Market 357
9.3.2 Duodenal Stent Market 359
9.3.3 Colonic Stent Market 361
9.3.4 Total Esophageal Dilation Balloon Market 363
9.3.4.1 Multi-Stage Esophageal Dilation Balloon Market 367
9.3.4.2 Single-Stage Esophageal Dilation Balloon Market 369
9.3.5 Duodenal Dilation Balloon Market 371
9.3.6 Colonic Dilation Balloon Market 373
9.4 DRIVERS AND LIMITERS 375
9.4.1 Esophageal Stent Market 375
9.4.1.1 Market Drivers 375
9.4.1.2 Market Limiters 376
9.4.2 Duodenal Stent Market 377
9.4.2.1 Market Drivers 377
9.4.2.2 Market Limiters 377
9.4.3 Colonic Stent Market 378
9.4.3.1 Market Drivers 378
9.4.3.2 Market Limiters 378
9.4.4 Esophageal Dilation Balloon Market 379
9.4.4.1 Market Drivers 379
9.4.4.2 Market Limiters 379
9.4.5 Duodenal Dilation Balloon Market 381
9.4.5.1 Market Drivers 381
9.4.5.2 Market Limiters 381
9.4.6 Colonic Dilation Balloon Market 383
9.4.6.1 Market Drivers 383
9.5 COMPETITIVE MARKET SHARE ANALYSIS 384
9.5.1 Stenting and Dilation Device Market 384
9.5.2 Esophageal Stent Market 388
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET 390
10.1 INTRODUCTION 390
10.2 MARKET OVERVIEW 391
10.3 MARKET ANALYSIS AND FORECAST 397
10.3.1 Sphincterotome Market 397
10.3.2 Biliary Stone Removal Balloon Market 399
10.3.3 Biliary Stone Removal Basket Market 401
10.3.4 Biliary Dilation Balloon Market 403
10.3.5 Total Biliary and Pancreatic Stent Market 405
10.3.5.1 Total Biliary and Pancreatic Covered-Metal Stent Market 409
10.3.5.1.1 Biliary and Pancreatic Standard Covered-Metal Stent Market 413
10.3.5.1.2 Biliary and Pancreatic Lumen-Apposing Covered-Metal Stent Market 415
10.3.5.2 Biliary and Pancreatic Bare-Metal Stent Market 417
10.3.5.3 Biliary and Pancreatic Plastic Stent Market 419
10.3.6 Biliary Lithotripter Market 421
10.3.7 ERCP Guidewire Market 423
10.3.8 ERCP Cannula Market 425
10.4 DRIVERS AND LIMITERS 427
10.4.1 Market Drivers 427
10.4.2 Market Limiters 427
10.5 COMPETITIVE MARKET SHARE ANALYSIS 429
10.5.1 ERCP Device Market 429
10.5.2 Biliary and Pancreatic Stent Market 433
BIOPSY FORCEPS, POLYPECTOMY SNARE AND EUS NEEDLE MARKET 435
11.1 INTRODUCTION 435
11.2 MARKET OVERVIEW 436
11.3 MARKET ANALYSIS AND FORECAST 440
11.3.1 Total Biopsy Forceps Market 440
11.3.1.1 Cold Disposable Biopsy Forceps Market 444
11.3.1.2 Hot Disposable Biopsy Forceps Market 446
11.3.1.3 Cold Reusable Biopsy Forceps Market 448
11.3.1.4 Hot Reusable Biopsy Forceps Market 450
11.3.2 Polypectomy Snare Market 452
11.3.3 Total EUS Needle Market 454
11.3.3.1 Fine Needle Aspiration Market 458
11.3.3.2 Fine Needle Biopsy Market 460
11.4 DRIVERS AND LIMITERS 462
11.4.1 Biopsy Forceps Market 462
11.4.1.1 Market Drivers 462
11.4.1.2 Market Limiters 462
11.4.2 Polypectomy Snare Market 464
11.4.2.1 Market Drivers 464
11.4.2.2 Market Limiters 464
11.4.3 EUS Needle Market 466
11.4.3.1 Market Drivers 466
11.4.3.2 Market Limiters 466
11.5 COMPETITIVE MARKET SHARE ANALYSIS 467
11.5.1 Biopsy Forceps Market 471
11.5.2 EUS Needle Market 473
SPECIMEN RETRIEVAL AND FOREIGN-BODY REMOVAL DEVICE MARKET 475
12.1 INTRODUCTION 475
12.2 MARKET OVERVIEW 476
12.3 MARKET ANALYSIS AND FORECAST 480
12.3.1 Total Specimen Retrieval Device Market 480
12.3.1.1 Polyp Retrieval Trap Market 484
12.3.1.2 Specimen Retrieval Net Market 486
12.3.2 Total Foreign-Body Removal Device Market 488
12.3.2.1 Foreign-Body Removal Net Market 492
12.3.2.2 Foreign-Body Removal Grasper Market 494
12.3.2.3 Foreign-Body Removal Snare Market 496
12.4 DRIVERS AND LIMITERS 498
12.4.1 Market Drivers 498
12.4.2 Market Limiters 499
12.5 COMPETITIVE MARKET SHARE ANALYSIS 500
12.5.1 Specimen Retrieval and Foreign-Body Removal Device Market 500
12.5.2 Specimen Retrieval Device Market 503
12.5.3 Foreign-Body Removal Device Market 505
HEMOSTASIS DEVICE MARKET 507
13.1 INTRODUCTION 507
13.2 MARKET OVERVIEW 509
13.3 MARKET ANALYSIS AND FORECAST 514
13.3.1 Total Electrosurgical Generator Market 514
13.3.1.1 Electrosurgical Unit Market 518
13.3.1.2 Argon Module Market 521
13.3.2 Total Hemostasis Probe Market 523
13.3.2.1 Total Electrosurgical Probe Market 527
13.3.2.1.1 Conventional Electrosurgical Probe Market 531
13.3.2.1.2 Injection-Needle Probe Market 533
13.3.2.2 Heat Probe Market 535
13.3.2.3 Argon Probe Market 537
13.3.3 Total Ligation Device Market 539
13.3.3.1 Ligation Band Market 543
13.3.3.2 Ligation Clip Market 545
13.3.4 Sclerotherapy Needle Market 547
13.4 DRIVERS AND LIMITERS 549
13.4.1 Market Drivers 549
13.4.2 Market Limiters 549
13.5 COMPETITIVE MARKET SHARE ANALYSIS 551
13.5.1 Hemostasis Device Market 551
13.5.2 Electrosurgical Generator Market 555
13.5.3 Hemostasis Probe Market 557
13.5.4 Electrosurgical Probe Market 559
13.5.5 Ligation Device Market 561
ENTERAL FEEDING DEVICE MARKET 563
14.1 INTRODUCTION 563
14.2 MARKET OVERVIEW 564
14.3 MARKET ANALYSIS AND FORECAST 568
14.3.1 Enteral Feeding Pump Market 568
14.3.2 Total Feeding Tube Market 571
14.3.2.1 Total PEG Tube Market 576
14.3.2.1.1 Initial Placement PEG Tube Market 580
14.3.2.1.2 Total Replacement PEG Tube Market 582
14.3.2.2 DPEJ Tube Market 592
14.3.2.3 PEG-J Tube Market 594
14.3.2.4 NG/NJ Tube Market 596
14.3.3 Feeding Set Market 598
14.4 DRIVERS AND LIMITERS 600
14.4.1 Market Drivers 600
14.4.2 Market Limiters 601
14.5 COMPETITIVE MARKET SHARE ANALYSIS 602
14.5.1 Enteral Feeding Device Market 602
14.5.2 Feeding Tube Market 605
14.5.2.1 PEG Tube Market 607
ANTI-REFLUX DEVICE MARKET 609
15.1 INTRODUCTION 609
15.2 MARKET LANDSCAPE 611
15.3 MARKET ANALYSIS AND FORECAST 613
15.4 DRIVERS AND LIMITERS 616
15.4.1 Market Drivers 616
15.4.2 Market Limiters 617
15.5 COMPETITIVE MARKET SHARE ANALYSIS 618
BARRETT’S ESOPHAGUS ABLATION DEVICE MARKET 621
16.1 INTRODUCTION 621
16.2 MARKET OVERVIEW 622
16.3 MARKET ANALYSIS AND FORECAST 626
16.3.1 Ablation Device Market 626
16.3.2 Ablation Catheter Market 628
16.4 DRIVERS AND LIMITERS 630
16.4.1 Market Drivers 630
16.4.2 Market Limiters 630
16.5 COMPETITIVE MARKET SHARE ANALYSIS 632
ABBREVIATIONS 635

Chart 1 1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 – 2025 2
Chart 16 2: Endoscopic Gastrointestinal Device Market Overview, U.S., 2018 & 2025 2
Chart 4 1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 – 2025 169
Chart 4 2: Endoscopic Gastrointestinal Device Market Breakdown, U.S., 2018 170
Chart 4 3: Endoscopic Gastrointestinal Device Market Breakdown, U.S., 2025 171
Chart 4 4: Growth Rates by Segment, Endoscopic Gastrointestinal Device Market, U.S., 2015 – 2025 175
Chart 4 5: Leading Competitors, Gastrointestinal Endoscopic Device Market, U.S., 2018 184
Chart 5 1: Total Gastrointestinal Procedures by Type, U.S., 2015 – 2025 243
Chart 5 2: Gastrointestinal Endoscopy Procedures, U.S., 2015 – 2025 248
Chart 5 3: Capsule Endoscopy Procedures, U.S., 2015 – 2025 250
Chart 5 4: Virtual Endoscopy Procedures, U.S., 2015 – 2025 252
Chart 5 5: Stenting Procedures by Anatomy, U.S., 2015 – 2025 254
Chart 5 6: Dilation Procedures by Anatomy, U.S., 2015 – 2025 256
Chart 5 7: Tissue Biopsy Procedures by Modality, U.S., 2015 – 2025 258
Chart 5 8: Polypectomy Snare Procedures, U.S., 2015 – 2025 260
Chart 5 9: Specimen Retrieval Procedures, U.S., 2015 – 2025 262
Chart 5 10: Foreign-Body Removal Procedures, U.S., 2015 – 2025 264
Chart 5 11: Hemostasis Procedures, U.S., 2015 – 2025 266
Chart 5 12: Enteral Feeding Tube Placement Procedures, U.S., 2015 – 2025 268
Chart 5 13: Anti-Reflux Device Implantation Procedures, U.S., 2015 – 2025 270
Chart 5 14: Barrett’s Esophagus Ablation Procedures, U.S., 2015 – 2025 272
Chart 6 1: Gastrointestinal Endoscope Market by Segment, U.S., 2015 – 2025 278
Chart 6 2: Gastrointestinal Endoscope Market Breakdown, U.S., 2018 279
Chart 6 3: Gastrointestinal Endoscope Market Breakdown, U.S., 2025 280
Chart 6 4: Total Gastrointestinal Endoscope Market, U.S., 2015 – 2025 282
Chart 6 5: Colonoscope Market, U.S., 2015 – 2025 285
Chart 6 6: Sigmoidoscope Market, U.S., 2015 – 2025 287
Chart 6 7: Duodenoscope Market, U.S., 2015 – 2025 289
Chart 6 8: Enteroscope Market, U.S., 2015 – 2025 291
Chart 6 9: Ultrasound Endoscope Market, U.S., 2015 – 2025 293
Chart 6 10: Double-Balloon Endoscope Market, U.S., 2015 – 2025 295
Chart 6 11: Gastroscope Market, U.S., 2015 – 2025 297
Chart 6 12: Third-Party Refurbished Endoscope Market, U.S., 2015 – 2025 299
Chart 6 13: Leading Competitors, Gastrointestinal Endoscope Market, U.S., 2018 306
Chart 6 14: Leading Competitors, Third-Party Endoscope Refurbishment and Repair Market, U.S., 2018 309
Chart 7 1: Capsule Endoscopy Market by Segment, U.S., 2015 – 2025 313
Chart 7 2: Capsule Endoscopy Market Breakdown, U.S., 2018 314
Chart 7 3: Capsule Endoscopy Market Breakdown, U.S., 2025 315
Chart 7 4: Camera Capsule Market, U.S., 2015 – 2025 318
Chart 7 5: Workstation Market, U.S., 2015 – 2025 320
Chart 7 6: Data Recorder Market, U.S., 2015 – 2025 322
Chart 7 7: Leading Competitors, Capsule Endoscopy Market, U.S., 2018 328
Chart 8 1: Virtual Colonoscopy Software Market, U.S., 2015 – 2025 333
Chart 8 2: Leading Competitors, Virtual Colonoscopy Software Market, U.S., 2018 340
Chart 9 1: Stenting and Dilation Device Market by Segment, U.S., 2015 – 2025 345
Chart 9 2: Stenting and Dilation Device Market Breakdown, U.S., 2018 346
Chart 9 3: Stenting and Dilation Device Market Breakdown, U.S., 2025 347
Chart 9 4: Esophageal Stent Market by Segment, U.S., 2015 – 2025 350
Chart 9 5: Total Esophageal Stent Market, U.S., 2015 – 2025 352
Chart 9 6: Esophageal Covered-Metal Stent Market, U.S., 2015 – 2025 354
Chart 9 7: Esophageal Bare-Metal Stent Market, U.S., 2015 – 2025 356
Chart 9 8: Esophageal Plastic Stent Market, U.S., 2015 – 2025 358
Chart 9 9: Duodenal Stent Market, U.S., 2015 – 2025 360
Chart 9 10: Colonic Stent Market, U.S., 2015 – 2025 362
Chart 9 11: Esophageal Dilation Balloon Market by Segment, U.S., 2015 – 2025 364
Chart 9 12: Total Esophageal Dilation Balloon Market, U.S., 2015 – 2025 366
Chart 9 13: Multi-Stage Esophageal Dilation Balloon Market, U.S., 2015 – 2025 368
Chart 9 14: Single-Stage Esophageal Dilation Balloon Market, U.S., 2015 – 2025 370
Chart 9 15: Duodenal Dilation Balloon Market, U.S., 2015 – 2025 372
Chart 9 16: Colonic Dilation Balloon Market, U.S., 2015 – 2025 374
Chart 9 17: Leading Competitors, Stenting and Dilation Device Market, U.S., 2018 387
Chart 9 18: Leading Competitors, Esophageal Stent Market, U.S., 2018 389
Chart 10 1: ERCP Device Market by Segment, U.S., 2015 – 2025 394
Chart 10 2: ERCP Device Market Breakdown, U.S., 2018 395
Chart 10 3: ERCP Device Market Breakdown, U.S., 2025 396
Chart 10 4: Sphincterotome Market, U.S., 2015 – 2025 398
Chart 10 5: Biliary Stone Removal Balloon Market, U.S., 2015 – 2025 400
Chart 10 6: Biliary Stone Removal Basket Market, U.S., 2015 – 2025 402
Chart 10 7: Biliary Dilation Balloon Market, U.S., 2015 – 2025 404
Chart 10 8: Biliary and Pancreatic Stent Market by Segment, U.S., 2015 – 2025 406
Chart 10 9: Total Biliary and Pancreatic Stent Market, U.S., 2015 – 2025 408
Chart 10 10: Biliary and Pancreatic Covered-Metal Stent Market by Segment, U.S., 2015 – 2025 410
Chart 10 11: Total Biliary and Pancreatic Covered-Metal Stent Market, U.S., 2015 – 2025 412
Chart 10 12: Biliary and Pancreatic Standard Covered-Metal Stent Market, U.S., 2015 – 2025 414
Chart 10 13: Biliary and Pancreatic Lumen-Apposing Covered-Metal Stent Market, U.S., 2015 – 2025 416
Chart 10 14: Biliary and Pancreatic Bare-Metal Stent Market, U.S., 2015 – 2025 418
Chart 10 15: Biliary and Pancreatic Plastic Stent Market, U.S., 2015 – 2025 420
Chart 10 16: Biliary Lithotripter Market, U.S., 2015 – 2025 422
Chart 10 17: ERCP Guidewire Market, U.S., 2015 – 2025 424
Chart 10 18: ERCP Cannula Market, U.S., 2015 – 2025 426
Chart 10 19: Leading Competitors, ERCP Device Market, U.S., 2018 432
Chart 10 20: Leading Competitors, Biliary and Pancreatic Stent Market, U.S., 2018 434
Chart 11 1: Biopsy Forceps, Polypectomy Snare and EUS Needle Market by Segment, U.S., 2015 – 2025 437
Chart 11 2: Biopsy Forceps, Polypectomy Snare and EUS Needle Market Breakdown, U.S., 2018 438
Chart 11 3: Biopsy Forceps, Polypectomy Snare and EUS Needle Market Breakdown, U.S., 2025 439
Chart 11 4: Biopsy Forceps Market by Segment, U.S., 2015 – 2025 441
Chart 11 5: Total Biopsy Forceps Market, U.S., 2015 – 2025 443
Chart 11 6: Cold Disposable Biopsy Forceps Market, U.S., 2015 – 2025 445
Chart 11 7: Hot Disposable Biopsy Forceps Market, U.S., 2015 – 2025 447
Chart 11 8: Cold Reusable Biopsy Forceps Market, U.S., 2015 – 2025 449
Chart 11 9: Hot Reusable Biopsy Forceps Market, U.S., 2015 – 2025 451
Chart 11 10: Polypectomy Snare Market, U.S., 2015 – 2025 453
Chart 11 11: EUS Needle Market by Segment, U.S., 2015 – 2025 455
Chart 11 12: Total EUS Needle Market, U.S., 2015 – 2025 457
Chart 11 13: Fine Needle Aspiration Market, U.S., 2015 – 2025 459
Chart 11 14: Fine Needle Biopsy Market, U.S., 2015 – 2025 461
Chart 11 15: Leading Competitors, Biopsy Forceps, Polypectomy Snare and EUS Needle Market, U.S., 2018 470
Chart 11 16: Leading Competitors, Biopsy Forceps Market, U.S., 2018 472
Chart 11 17: Leading Competitors, EUS Needle Market, U.S., 2018 474
Chart 12 1: Specimen retrieval and foreign-body removal Device Market by Segment, U.S., 2015 – 2025 477
Chart 12 2: Specimen retrieval and foreign-body removal Device Market Breakdown, U.S., 2018 478
Chart 12 3: Specimen retrieval and foreign-body removal Device Market Breakdown, U.S., 2025 479
Chart 12 4: Specimen Retrieval Device Market by Segment, U.S., 2015 – 2025 481
Chart 12 5: Total Specimen Retrieval Device Market, U.S., 2015 – 2025 483
Chart 12 6: Polyp Retrieval Trap Market, U.S., 2015 – 2025 485
Chart 12 7: Specimen Retrieval Net Market, U.S., 2015 – 2025 487
Chart 12 8: Foreign-Body Removal Device Market by Segment, U.S., 2015 – 2025 489
Chart 12 9: Total Foreign-Body Removal Device Market, U.S., 2015 – 2025 491
Chart 12 10: Foreign-Body Removal Net Market, U.S., 2015 – 2025 493
Chart 12 11: Foreign-Body Removal Grasper Market, U.S., 2015 – 2025 495
Chart 12 12: Foreign-Body Removal Snare Market, U.S., 2015 – 2025 497
Chart 12 13: Leading Competitors, Specimen Retrieval and Foreign-Body Removal Device Market, U.S., 2018 502
Chart 12 14: Leading Competitors, Specimen Retrieval Device Market, U.S., 2018 504
Chart 12 15: Leading Competitors, Foreign-Body Removal Device Market, U.S., 2018 506
Chart 13 1: Hemostasis Device Market by Segment, U.S., 2015 – 2025 511
Chart 13 2: Hemostasis Device Market Breakdown, U.S., 2018 512
Chart 13 3: Hemostasis Device Market Breakdown, U.S., 2025 513
Chart 13 4: Electrosurgical Generator Market by Segment, U.S., 2015 – 2025 515
Chart 13 5: Total Electrosurgical Generator Market, U.S., 2015 – 2025 517
Chart 13 6: Electrosurgical Unit Market, U.S., 2015 – 2025 520
Chart 13 7: Argon Module Market, U.S., 2015 – 2025 522
Chart 13 8: Hemostasis Probe Market by Segment, U.S., 2015 – 2025 524
Chart 13 9: Total Hemostasis Probe Market, U.S., 2015 – 2025 526
Chart 13 10: Electrosurgical Probe Device Market by Segment, U.S., 2015 – 2025 528
Chart 13 11: Total Electrosurgical Probe Market, U.S., 2015 – 2025 530
Chart 13 12: Conventional Electrosurgical Probe Market, U.S., 2015 – 2025 532
Chart 13 13: Injection-Needle Probe Market, U.S., 2015 – 2025 534
Chart 13 14: Heat Probe Market, U.S., 2015 – 2025 536
Chart 13 15: Argon Probe Market, U.S., 2015 – 2025 538
Chart 13 16: Ligation Device Market by Segment, U.S., 2015 – 2025 540
Chart 13 17: Total Ligation Device Market, U.S., 2015 – 2025 542
Chart 13 18: Ligation Band Market, U.S., 2015 – 2025 544
Chart 13 19: Ligation Clip Market, U.S., 2015 – 2025 546
Chart 13 20: Sclerotherapy Needle Market, U.S., 2015 – 2025 548
Chart 13 21: Leading Competitors, Hemostasis Device Market, U.S., 2018 554
Chart 13 22: Leading Competitors, Electrosurgical Generator Market, U.S., 2018 556
Chart 13 23: Leading Competitors, Hemostasis Probe Market, U.S., 2018 558
Chart 13 24: Leading Competitors, Electrosurgical Probe Market, U.S., 2018 560
Chart 13 25: Leading Competitors, Ligation Device Market, U.S., 2018 562
Chart 14 1: Enteral Feeding Device Market by Segment, U.S., 2015 – 2025 565
Chart 14 2: Enteral Feeding Device Market Breakdown, U.S., 2018 566
Chart 14 3: Enteral Feeding Device Market Breakdown, U.S., 2025 567
Chart 14 4: Enteral Feeding Pump Market, U.S., 2015 – 2025 570
Chart 14 5: Feeding Tube Market by Segment, U.S., 2015 – 2025 573
Chart 14 6: Total Feeding Tube Market, U.S., 2015 – 2025 575
Chart 14 7: PEG Tube Market by Segment, U.S., 2015 – 2025 577
Chart 14 8: Total PEG Tube Market, U.S., 2015 – 2025 579
Chart 14 9: Initial Placement PEG Tube Market, U.S., 2015 – 2025 581
Chart 14 10: Replacement PEG Tube Market by Segment, U.S., 2015 – 2025 583
Chart 14 11: Total Replacement PEG Tube Market, U.S., 2015 – 2025 585
Chart 14 12: Replacement Traditional Tube Market, U.S., 2015 – 2025 587
Chart 14 13: Replacement Low-Profile Balloon Tube Market, U.S., 2015 – 2025 589
Chart 14 14: Replacement Low-Profile Non-Balloon Tube Market, U.S., 2015 – 2025 591
Chart 14 15: DPEJ Tube Market, U.S., 2015 – 2025 593
Chart 14 16: PEG-J Tube Market, U.S., 2015 – 2025 595
Chart 14 17: NG/NJ Tube Market, U.S., 2015 – 2025 597
Chart 14 18: Feeding Set Market, U.S., 2015 – 2025 599
Chart 14 19: Leading Competitors, Enteral Feeding Device Market, U.S., 2018 604
Chart 14 20: Leading Competitors, Feeding Tube Market, U.S., 2018 606
Chart 14 21: Leading Competitors, PEG Tube Market, U.S., 2018 608
Chart 15 1: Anti-Reflux Device Market, U.S., 2015 – 2025 615
Chart 15 2: Leading Competitors, Anti-Reflux Device Market, U.S., 2018 620
Chart 16 1: Barrett’s Esophagus Ablation Device Market by Segment, U.S., 2015 – 2025 623
Chart 16 2: Barrett’s Esophagus Ablation Device Market Breakdown, U.S., 2018 624
Chart 16 3: Barrett’s Esophagus Ablation Device Market Breakdown, U.S., 2025 625
Chart 16 4: Ablation Device Market, U.S., 2015 – 2025 627
Chart 16 5: Ablation Catheter Market, U.S., 2015 – 2025 629
Chart 16 6: Leading Competitors, Barrett’s Esophagus Ablation Device Market, U.S., 2018 634

Figure 16 1: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (1 of 3) 3
Figure 16 2: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (2 of 3) 4
Figure 16 3: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (3 of 3) 4
Figure 16 4: Companies Researched in this Report 5
Figure 16 5: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (1 of 2) 6
Figure 16 6: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (2 of 2) 7
Figure 16 7: Recent Events in the Endoscopic Gastrointestinal Device Market, U.S., 2016 – 2018 8
Figure 16 8: Endoscopic Gastrointestinal Device Procedures Covered 9
Figure 16 9: Procedure Codes Investigated 10
Figure 16 10: Endoscopic Gastrointestinal Device Markets Covered (1 of 3) 11
Figure 16 11: Endoscopic Gastrointestinal Device Markets Covered (2 of 3) 12
Figure 16 12: Endoscopic Gastrointestinal Device Markets Covered (3 of 3) 13
Figure 16 13: Key Report Updates 14
Figure 16 14: Version History 15
Figure 2 1: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 43
Figure 3 1: Gastrointestinal Endoscopy by Company (1 of 3) 52
Figure 3 2: Gastrointestinal Endoscopy by Company (2 of 3) 53
Figure 3 3: Gastrointestinal Endoscopy by Company (3 of 3) 54
Figure 3 4: Capsule Endoscopy by Company 57
Figure 3 5: Virtual Colonoscopy by Company 59
Figure 3 6: Stenting and Dilation Devices by Company 62
Figure 3 7: ERCP Devices by Company (1 of 3) 64
Figure 3 8: ERCP Devices by Company (2 of 3) 65
Figure 3 9: ERCP Devices by Company (3 of 3) 66
Figure 3 10: Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles by Company 68
Figure 3 11: Foreign Body Retrieval and Specimen Removal Devices by Company 70
Figure 3 12: Hemostasis Devices by Company 73
Figure 3 13: Enteral Feeding Devices by Company (1 of 3) 75
Figure 3 14: Enteral Feeding Devices by Company (2 of 3) 76
Figure 3 15: Enteral Feeding Devices by Company (3 of 3) 77
Figure 3 16: Anti-Reflux Devices by Company 79
Figure 3 17: Barrett’s Esophagus Ablation Devices by Company 81
Figure 3 18: Class 2 Device Recall Spyscope DS Access and Delivery Catheter 82
Figure 3 19:Class 2 Device Recall Extractor Pro RX 82
Figure 3 20: Class 2 Device Recall Expel Drainage Catheter with TwistLoc Hub Biliary Drainage Catheter and BiliaryDrainage Catheter Kit 82
Figure 3 21: Class 2 Device Recall Boston Scientific Extractor Pro XL Retrieval Balloon Catheter 83
Figure 3 22: Class 2 Device Recall Advance 35LP LowProfile PTA Balloon Dilatation Catheter 84
Figure 3 23: Class 2 Device Recall CheckFlo Introducer 84
Figure 3 24: Class 2 Device Recall Flexor CheckFlo Introducer 84
Figure 3 25: Class 2 Device Recall Ring Transjugular Intrahepatic Access Set & Flexor RTPS Guiding Sheath 85
Figure 3 26: Class 2 Device Recall Transluminal Biliary Biopsy Forceps Set 85
Figure 3 27: Class 2 Device Recall CheckFlo Hemostasis Assembly 85
Figure 3 28: Class 2 Device Recall FUJINON ED530XT 86
Figure 3 29: Class 2 Device Recall Fujifilm 86
Figure 3 30: Class 2 Device Recall Fujifilm 86
Figure 3 31: Class 2 Device Recall Fujifilm Endoscope 87
Figure 3 32: Class 2 Device Recall Dudenoscope 87
Figure 3 33: Class 2 Device Recall Fujifilm 87
Figure 3 34: Class 2 Device Recall Fujifilm 88
Figure 3 35: Class 2 Device Recall CORTRAK 2 Nasogastric/Nasointestinal (NG/NI) Feeding Tubes w/ ANTIIV Connector 88
Figure 3 36: Class 2 Device Recall OERPro Endoscope Reprocessor 89
Figure 3 37: Class 2 Device Recall EVIS EXERA Duodenovideoscope OLYMPUS TJF 160F/VF 89
Figure 3 38: Class 2 Device Recall Evis Exera II Duodenovideoscope Olympus TJFQ180V 89
Figure 3 39: Class 2 Device Recall MAJ1606 Instrument Channel Adaptor 89
Figure 3 40: Class 2 Device Recall EVIS EXERA II Gastrovideoscope OLYMPUS GF type UCT180 90
Figure 3 41: Class 2 Device Recall EVIS EXERA II Duodenovideoscope OLYMPUS TJF TypeQ180V 90
Figure 3 42: Class 2 Device Recall Pentax Video Duodenoscope 91
Figure 3 43: Class 2 Device Recall Ultrasound Video Gastroscope 91
Figure 3 44: Class 2 Device Recall 91
Figure 3 45: Class 2 Device Recall Pentax Video Duodenoscope 92
Figure 3 46: Class 2 Device Recall Pentax 92
Figure 3 47: Class 2 Device Recall Pentax Video Gastroscope 92
Figure 3 48: Class 2 Device Recall Pentax 92
Figure 3 49: Class 2 Device Recall Pentax 93
Figure 3 50: Class 2 Device Recall Pentax Medical 93
Figure 3 51: Class 2 Device Recall Pentax Medical Inc. 93
Figure 3 52: Class 2 Device Recall Pentax Medical Inc. 93
Figure 3 53: Class 3 Device Recall Roth Net Polyp Retrieval 94
Figure 3 54: Class 2 Device Recall Talon Grasping Device 94
Figure 3 55: Comparison of FCSEMS and Plastic Stents (WON-MVP) 95
Figure 3 56: AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study 95
Figure 3 57: WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture 96
Figure 3 58: TECR & ECM Placement for Esophageal High Grade Dysplasia 96
Figure 3 59: A Trial of Esophageal and Gastric Stenting for Leak or Perforation (ESO-stent) 96
Figure 3 60: Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction 97
Figure 3 61: Esophageal Fully Covered Metal Stents in Caustic Strictures Study 97
Figure 3 62: Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures (COPAC) 97
Figure 3 63: Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. (StentMig) 98
Figure 3 64: Cholangioscopic Classification of Bile Duct Lesions 98
Figure 3 65: Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures 98
Figure 3 66: SpyGlass AMEA Registry 99
Figure 3 67: Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures 99
Figure 3 68: POCS in Liver Transplantation Patients 99
Figure 3 69: SpyGlass Direct Visualization System Clinical Registry in China (SpyChina) 100
Figure 3 70: Effect of Endoscopic Papillary Large Balloon Dilation on Recurrent Rate of Patients With Recurrentstones in Bile Duct 100
Figure 3 71: Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications 100
Figure 3 72: Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary Stenosis 101
Figure 3 73: Prospective Evaluation of Residual Bile Duct Stone by Peroral Cholangioscopy After Conventional ERCP 101
Figure 3 74: Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP 101
Figure 3 75: Endoscopic Biliary RFA of Malignant Bile Duct Obstruction 102
Figure 3 76: Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma 102
Figure 3 77: Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla (EHL) 102
Figure 3 78: WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study 103
Figure 3 79: Short Term Pancreatic Stenting Registry 103
Figure 3 80: Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer 103
Figure 3 81: Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction 104
Figure 3 82: Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy 104
Figure 3 83: Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction 104
Figure 3 84: Non-Complex Biliary Stones DSC vs ERC 105
Figure 3 85: Pancreatic Metal Stents in Chronic Pancreatitis 105
Figure 3 86: WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures 105
Figure 3 87: WallFlex Biliary Fully Covered (FC) Benign Stricture Study 106
Figure 3 88: Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry 106
Figure 3 89: Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer 106
Figure 3 90: Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy 107
Figure 3 91: Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy 107
Figure 3 92: Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma 107
Figure 3 93: Laser Lithotripsy for Difficult Large Bile Duct Stones 108
Figure 3 94: Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer 108
Figure 3 95: EUS GUIDED Transduodenal Biopsy Using the 19G Flex (NIFLEX) 108
Figure 3 96: EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors 109
Figure 3 97: Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps 109
Figure 3 98: EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses 109
Figure 3 99: Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study 110
Figure 3 100: Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial. 110
Figure 3 101: Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles 110
Figure 3 102: Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions 111
Figure 3 103: Evaluation of PCLs Using Three EUS-FNA Needles 111
Figure 3 104: EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique (EUS-FNA) 111
Figure 3 105: Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population 112
Figure 3 106: Removal of the Evolution® Esophageal Stent - Fully Covered (CLARITY) 113
Figure 3 107: SX ELLA Esophageal Degradable BD Stent System (DESTINY) 113
Figure 3 108: Using Covered Stent of Diameter of 7mm in TIPS 114
Figure 3 109: Comparison of Covered and Bare Stent in TIPS 114
Figure 3 110: Evolution® Biliary Stent System Clinical Study 115
Figure 3 111: Pancreatic Stent for Distal Pancreatectomy 115
Figure 3 112: Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy 116
Figure 3 113: Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents 116
Figure 3 114: Comparison Between Fully Covered Metal Stents and Plastic Stents in Preoperative Biliary Drainage 116
Figure 3 115: Evolution® Biliary Stent System-Fully Covered 117
Figure 3 116: Pancreatic Duct Stent for Acute Necrotizing Pancreatitis 117
Figure 3 117: Endoscopic Biliary Drainage in Malignant High Grade Biliary Stricture 117
Figure 3 118: Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones 118
Figure 3 119: Comparison of Loop-tip Cook Medical® Wire Versus Traditional Endoscopic Technique (loop) 118
Figure 3 120: Comparison Of Loop-Tip Wire Vs Traditional Technique In The Cannulation Of The Common Bile Duct 118
Figure 3 121: Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle (MUCIN) 119
Figure 3 122: Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study 119
Figure 3 123: Endoscopic Ultrasound-guided Fine Needle Biopsy With 25-gauge Biopsy Needles for Solid Pancreatic Masses 119
Figure 3 124: Head to Head Comparison of Two Needles EUS Guided FNB 120
Figure 3 125: Comparison of Jumbo and Hot Biopsy Forceps 120
Figure 3 126: Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions 120
Figure 3 127: EUS-FNA With 22G Procore Needles vs 22G Conventional Needles 121
Figure 3 128: A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO) 121
Figure 3 129: Comparison of EUS-Guided Fine Needle Aspiration Technique 121
Figure 3 130: Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. 122
Figure 3 131: Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer (EMUNE-07) 122
Figure 3 132: EUS-guided Glue Injection for Varices Study 123
Figure 3 133: Study of Hemospray for Lower Gastrointestinal Hemorrhage 123
Figure 3 134: RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding 123
Figure 3 135: Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study 124
Figure 3 136: The EndoGastric Solutions TEMPO Trial (TEMPO) 125
Figure 3 137: Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study (RetroTIF) 125
Figure 3 138: Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study (RESPECT) 126
Figure 3 139: Hernia Reduction Prior to Scheduled TIF Completion (HEURISTIC) 126
Figure 3 140: Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) 126
Figure 3 141: Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD) 127
Figure 3 142: Registry to Compare Two Surgical Treatments for GERD (STAR Registry) 127
Figure 3 143: Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study 128
Figure 3 144: Hybrid APC Assisted EMR for Large Colon Polyps 128
Figure 3 145: PROSpective Assessment of Post EmR Recurrence (PROSPER) 129
Figure 3 146: A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01) 129
Figure 3 147: Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim 130
Figure 3 148: Resect and Discard Extension to FICE of NIcE Classification (FICE;NICE) 130
Figure 3 149: ColoAssist vs. MEI 130
Figure 3 150: Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions 131
Figure 3 151: Linked-color Imaging for the Detection of Colorectal Flat Lesions 131
Figure 3 152: Linked Color Imaging/Magnifying Blue Laser Imaging vs. White Light for Adenomas and Serrated Lesions in Proximal Colon 131
Figure 3 153: Blue Laser Imaging and White Light Imaging Colonic Polyps 132
Figure 3 154: Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH) 132
Figure 3 155: Double-balloon Colonoscopy to Increase Colonoscopy Completion Rate 132
Figure 3 156: Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease (BLINK) 133
Figure 3 157: A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD). (PCE) 133
Figure 3 158: Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects 134
Figure 3 159: Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population. (TOPAZ) 134
Figure 3 160: Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease (UC) 134
Figure 3 161: Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure 135
Figure 3 162: Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers ("HEIGHT" Study) 135
Figure 3 163: Development of Applications of the ® PillCam Endoscopy System and Evaluation of Their Performance (NOISE) 135
Figure 3 164: Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy 136
Figure 3 165: Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin 136
Figure 3 166: Capsule Endoscopy for Hemorrhage in the Emergency Room (CHEER) 136
Figure 3 167: Capsule Endoscopy for HEmorrhage in the ER (CHEER) 137
Figure 3 168: PillCam SBC System Functionality in Established and Suspected IBD Patients (PIANO) 137
Figure 3 169: Retrospective Collection of PillCam SB Movies (OCEAN) 137
Figure 3 170: Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis 138
Figure 3 171: Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening (FAMCAP) 138
Figure 3 172: RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia (REACH) 139
Figure 3 173: A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia 139
Figure 3 174: A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System (AIN) 139
Figure 3 175: Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa (RAGE) 140
Figure 3 176: The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS) (EMPRESS) 140
Figure 3 177: Radiofrequency Ablation in Patients With Barrett's Esophagus (RABE) 140
Figure 3 178: HALO Patient Registry: Ablation of Barrett's Esophagus 141
Figure 3 179: Ablation of Intestinal Metaplasia Containing Dysplasia 141
Figure 3 180: Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital (EXPECT) 141
Figure 3 181: Cytosponge Adequacy Study Evaluation II (CASEII) 142
Figure 3 182: Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy 142

The "United States Report for Gastrointestinal Endoscopic Devices 2019 - MedSuite" includes analysis on the following companies currently active in this market:
Boston Scientific
Olympus
Cardinal Health
Cook Medical
Medtronic
Moog
Avanos Medical
Medline
Fujifilm
Pentax
STERIS/US Endoscopy
Torax Medical
CONMED
GE Healthcare
Others include: BARD, CapsoVision, Carestream, CORPAK, Diversatek Healthcare, Endo-Therapeutics, IntroMedic, MedService International, Micro-Tech Endoscopy,
Mobile Instruments, Northfield Instruments, Rendoscopy, Vygon.
*Not all companies are currently active in every segment or report from this suite. For more details contact an iData Research Product Advisor.

$10,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

[email protected]
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

[email protected]
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838
+1 212 564 8133 fax